HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activated protein C prevents deleterious effects of remote reperfusion injury caused by intestinal ischemia on wound healing in the left colonic anastomoses: an experimental study in the murine model.

AbstractBACKGROUND:
Activated protein C (APC) is a serine protease with anticoagulant and antiinflammatory activities. The delaying effects of remote reperfusion injury on the wound-healing process in colonic anastomoses have been previously shown. In this study, we aimed to investigate whether APC protects against deleterious systemic effects of intestinal ischemia/reperfusion (I/R) injury on colonic anastomotic wound healing process.
METHODS:
Male Wistar-albino rats were randomly allocated into 4 groups, and a left colonic anastomosis was performed in all animals: (1) sham-operated group, simultaneously with left colonic anastomosis, the superior mesenteric artery and collateral branches were divided from the celiac axis, and the inferior mesenteric artery were isolated but not occluded (group 1, n = 12), (2) sham + APC group, identical to group 1 except for APC treatment (100 microg/kg, intravenously, 15 minutes before construction of the colonic anastomosis), (group 2, n = 12), (3) intestinal I/R group, 60 minutes of superior mesenteric ischemia followed by reperfusion (group 3, n = 12), and (4) APC-treated group, (100 microg/kg, intravenously, 15 minutes before reperfusion) (group 4, n = 12). All animals were sacrificed, and colonic anastomotic bursting pressures were measured in vivo on day 7. Tissue samples were obtained for analysis of hydroxyproline contents, nitrate/nitrite levels, and activities of oxidative and antioxidative enzymes. The plasma levels of proinflammatory cytokines and D-dimer were also measured.
RESULTS:
Intestinal I/R led to significant decreases in colonic anastomotic bursting pressures, tissue hydroxyproline contents, and activities of antioxidative enzymes, along with increases in tissue nitrate/nitrite levels, activities of oxidative enzymes, and plasma levels of proinflammatory cytokines and D-dimer (P < .05). However, APC treatment led to significant increases in colonic anastomotic bursting pressures, tissue hydroxyproline contents, and activities of antioxidative enzymes, along with decreases in tissue nitrate/nitrite levels, activities of oxidative enzymes, and plasma levels of proinflammatory cytokines and D-dimer (P < .05).
CONCLUSION:
This study clearly showed that APC treatment prevented the delaying effects of remote I/R injury on colonic anastomotic wound healing process. Further clinical studies are required to determine whether APC has a useful role in the enhancement of colonic anastomotic wound healing after particular operations in which I/R injury occurs.
AuthorsZafer Teke, Mustafa Sacar, Cigdem Yenisey, A Ozgur Atalay, Tuncay Bicakci, Ergun Erdem
JournalAmerican journal of surgery (Am J Surg) Vol. 196 Issue 5 Pg. 774-87 (Nov 2008) ISSN: 1879-1883 [Electronic] United States
PMID18466864 (Publication Type: Journal Article)
Chemical References
  • Interleukin-6
  • Nitrates
  • Nitrites
  • Protein C
  • Tumor Necrosis Factor-alpha
  • Malondialdehyde
  • Peroxidase
  • Xanthine Oxidase
  • Glutathione Reductase
  • Glutathione
Topics
  • Analysis of Variance
  • Anastomosis, Surgical
  • Animals
  • Chi-Square Distribution
  • Glutathione (metabolism)
  • Glutathione Reductase (metabolism)
  • Interleukin-6 (metabolism)
  • Intestines (blood supply, surgery)
  • Ischemia (complications, prevention & control)
  • Male
  • Malondialdehyde (metabolism)
  • Mesenteric Arteries (surgery)
  • Mice
  • Nitrates (metabolism)
  • Nitrites (metabolism)
  • Peroxidase (metabolism)
  • Protein C (pharmacology)
  • Random Allocation
  • Reperfusion Injury (etiology, prevention & control)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Wound Healing (drug effects)
  • Xanthine Oxidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: